جست‌وجوی استاد و پژوهشگر

Aditi Dasمشاهده پروفایل

استاد

• Biochemistry and Chemical biology of Lipids
• Mechanism of Membrane proteins in Nanodiscs
• Enzymology of metalloproteins
• +۵ مورد دیگر

Aditi Das is a Full Professor in the School of Chemistry and Biochemistry at the Georgia Institute of Technology, College of Sciences. She leads the Das Laboratory, which focuses on the biochemistry and chemical biology of lipids, particularly studying cytochrome P450 enzymes and their role in lipid metabolism, endocannabinoid systems, and inflammatory pathways. Her educational background includes: B.Sc. in Chemistry from St. Stephen's College M.Sc. in Chemistry from Indian Institute of Technology, Kanpur (I.I.T) Ph.D. in Chemistry from Princeton University Postdoctoral research at Northwestern University (NSF-NSEC fellow) and Beckman Institute for Advanced Science and Technology, University of Illinois UC Professor Das's research interests center around understanding the physiological role of lipids in sustaining homeostasis and their implications in disease states such as neurodegenerative disorders, cancer, and cardiovascular diseases. Her laboratory specializes in: Enzymology of cytochrome P450s, particularly CYP2J2 epoxygenase Metabolism of ω-3 and ω-6 fatty acids and their derivatives Minor cannabinoid metabolism by cytochrome P450 enzymes Discovery of novel anti-inflammatory lipid metabolites and endocannabinoids Mechanistic studies of membrane proteins using nanodisc technology Her work bridges biochemistry, chemical biology, and pharmacology to uncover novel therapeutic targets related to lipid signaling pathways. Analysis of Professor Das's recent publications (2023-2025) reveals a strong focus on cannabinoid metabolism by cytochrome P450 enzymes, with particular emphasis on how these metabolic processes generate bioactive compounds that interact with the endocannabinoid system. Her research increasingly explores the therapeutic potential of omega-3 derived endocannabinoid epoxides in inflammatory and neurodegenerative conditions. The use of nanodisc technology for studying membrane proteins in near-native environments remains a consistent methodological thread throughout her work, enabling detailed mechanistic insights into enzyme function. Professor Das has received numerous prestigious awards recognizing her research excellence and teaching: 2024 NIH Outstanding Researcher Award (MIRA R35) for established investigators 2024 Vasser Woolley Faculty Fellowship 2023 Plenary Lecture at the International Society of the Study of Xenobiotics (ISSX) 2021 E.L.R. Stokstad Award 2019-2021 List of Teachers Ranked as Excellent 2019 Eicosanoid Research Foundation Young Investigator Award 2019 Zoetis Research Excellence Award 2019 Mary Swartz Rose Young Investigator Award 2015 National Scientist Development Award from the American Heart Association 2022 El Sohly Award from the American Chemical Society Professor Das actively mentors a diverse group of students and postdoctoral researchers, with several former lab members now holding faculty positions or working at prestigious institutions. Her laboratory has secured significant funding from NIH, NSF, and other sources to support research on lipid metabolism, cannabinoid pharmacology, and membrane protein biochemistry. Notable grants include an NIH R35 Outstanding Investigator Award (MIRA), an NIH R21 grant from NIDA, and multiple collaborative grants with other research groups. The Das Laboratory operates within the Petit Institute of Bioengineering and Biosciences (IBB) at Georgia Tech, utilizing state-of-the-art facilities for biochemical and biophysical studies. The lab specializes in nanodisc technology to study membrane proteins in near-native environments, with particular expertise in cytochrome P450 enzymes and their interactions with lipid substrates. Recent work has expanded into collaborative projects involving lipidomics, structural biology, and translational applications of lipid signaling research.

Sarah Woolf-Kingمشاهده پروفایل

استادیار مدعو

• Clinical Psychology
• HIV/AIDS
• Substance Use
• +۹ مورد دیگر

Sarah Woolf-King is an Assistant Adjunct Professor in the Department of Medicine at the University of California, San Francisco (UCSF), School of Medicine. She is a licensed clinical psychologist (CA PSY28178) whose research bridges psychology and health, with a strong focus on substance use, HIV, and mental health in families affected by congenital heart defects. Her educational background includes a B.S. in Psychology from Arizona State University (2002), an M.S./Ph.D. in Clinical Psychology from Syracuse University (2010), an M.P.H. in Epidemiology from UC Berkeley (2011), a clinical internship in Behavioral Medicine at VA Palo Alto (2010), and a T32 Postdoctoral Fellowship at UCSF’s Center for AIDS Prevention Studies (2013). Dr. Woolf-King’s research centers on two primary areas: (1) the impact of alcohol use on HIV treatment and prevention, particularly among HIV-positive men who have sex with men (MSM) and in East African populations, and (2) the mental health needs of parents of children with critical congenital heart defects (CHD). Her work employs diverse methodologies, including daily data collection, qualitative interviews, randomized trials, and biomarker validation (e.g., PEth). She aims to develop integrated behavioral interventions to improve health outcomes for individuals and families coping with chronic illness. Her recent publications (2023–2025) reflect a consistent focus on alcohol use in the context of HIV, with studies on counseling interventions, digital screening, remote biomarker collection, and behavioral mechanisms. There is also growing attention to mental health in vulnerable populations, including college students and parents of children with genetic or cardiac conditions. Her work is increasingly interdisciplinary, combining psychology, epidemiology, public health, and global health. Scientific Awards: Hellman Fellow, Hellman Fellows Fund (2015–2017) Mentored Research Scientist Development Award (K01), NIH/NIAAA (2013–2018) Loan Repayment Program in Clinical Research, NIH/NIAAA (2011–2016) Ruth L. Kirschstein National Research Service Award (F31), NIH/NIAAA (2008–2010) Mentored Scientist Award in HIV/AIDS, UCSF CFAR (2012–2014) Dr. Woolf-King has served as Principal Investigator on NIH-funded projects, including an R34 grant for a brief ACT intervention for HIV-positive hazardous drinkers and a K01 grant on alcohol and sexual risk behavior. She collaborates extensively with researchers at UCSF and in East Africa, particularly Uganda. While her adjunct title suggests a part-time or non-tenure-track role, she maintains an active research program with significant grant support and a robust publication record. There is no indication of retirement or former staff status.

Kristina Schoonjansمشاهده پروفایل

دانشیار

• Bile acid signaling
• Nutrient sensing
• Intermediary metabolism
• +۱۱ مورد دیگر

Kristina Schoonjans is an Associate Professor at EPFL’s School of Life Sciences, where she leads the Laboratory of Metabolic Signaling (UPSCHOONJANS). Her research focuses on the molecular mechanisms of bile acid signaling, nutrient sensing, and intermediary metabolism, particularly in the context of metabolic disorders such as obesity, fatty liver disease, and cancer. She investigates how the liver-gut-brain axis integrates metabolic signals through nuclear receptors and mitochondrial dynamics. Her research interests include: Bile acid signaling and its role as a hormonal regulator Nutrient and metabolite sensing in energy homeostasis Intermediary metabolism and metabolic disorders Role of nuclear receptors (e.g., TGR5, LRH-1) in liver, gut, and adipose tissue Mitochondrial dynamics and fission in metabolic regulation Organoid models for studying liver and intestinal metabolism Systems genetics using BXD mouse populations The most recent articles highlight a strong focus on bile acid signaling, particularly through TGR5 and LRH-1, in regulating metabolic health. Themes include the conversion of white fat to beige fat (beiging), hepatic tumorigenesis, mitochondrial fission, and the use of organoid and genetically engineered mouse models. There is a consistent emphasis on translational applications for obesity, fatty liver disease, and cancer. Scientific honors include: Windaus Prize from the Dr. Falk Foundation (2010, shared with Johan Auwerx) for the discovery of the signaling/endocrine function of bile acids Prof. Schoonjans actively supervises PhD students and has advised numerous doctoral candidates who have since completed their theses. Her lab is supported by multiple grants from Swiss and international funding agencies, including the Swiss National Science Foundation, EPFL, CONACYT, and the Foundation for Health and Education. She teaches in several doctoral programs at EPFL, including Life Sciences Engineering, and contributes to education through the SSV and EDBB/EDCB/EDMS-ENS programs. The Schoonjans Lab brings together scientists, doctoral assistants, and technicians working on projects related to metabolic signaling. The team uses advanced techniques such as genetically modified mouse models, organoid cultures, and multi-omics (metabolomics, proteomics, transcriptomics) to study the liver-gut and brain-liver axes. The lab has a strong track record of high-impact publications and collaborations with institutions worldwide.

Xenophon Papademetrisمشاهده پروفایل

استاد

• Medical Image Analysis
• Machine Learning
• Biomedical Software Development
• +۷ مورد دیگر

Xenophon Papademetris is a Professor of Biomedical Informatics & Data Science and Radiology & Biomedical Imaging at Yale School of Medicine. He serves as Associate Director of Biomedical Imaging Data Sciences at Yale Biomedical Imaging Institute and directs the Medical Software and Medical Artificial Intelligence Certificate Program. PhD in Electrical and Information Sciences from Yale University (2000) BA from Cambridge University (1994) Postdoctoral Fellowship at Yale University (2002) His research focuses on medical image analysis, machine learning, and biomedical software development. He has developed tools like BioImage Suite Web and contributed to standards committees at the Association for the Advancement of Medical Instrumentation (AAMI). His work spans modalities including MRI, CT, PET, and optical imaging. Recent publications emphasize neuroimaging analysis, explainable AI in healthcare, and multimodal data integration across species. He leads NIH-funded research under the BRAIN Initiative (R24 MH114805) and has authored a textbook on Medical Software published by Cambridge University Press. IEEE Senior Member Yale Brown-Coxe Postdoctoral Fellowship Harding Bliss Prize for Excellence in Engineering He directs the BioImage Suite Project, creating web-based image analysis tools using JavaScript and WebAssembly. His teaching includes both academic courses and a Coursera program on Medical Software with over 14,000 enrollments.

Rodolfo J. Floresمشاهده پروفایل

استادیار

• Behavioral Neuroscience
• Neuromodulators
• Prefrontal Cortex Function
• +۳ مورد دیگر

Dr. Rodolfo J. Flores serves as an Assistant Professor in the Department of Psychology within the College of Liberal Arts at the University of Texas at El Paso (UTEP). His primary research investigates neuromodulator function in the prefrontal cortex, with emphasis on acetylcholine and dynorphin systems during motivational conflict, stress responses, and addiction pathways. He employs advanced optogenetic and biosensor technologies to dissect neural circuitry underlying psychiatric conditions. Dr. Flores earned his Ph.D. in Social Cognitive and Neuroscience from UTEP in 2019, followed by postdoctoral training at the National Institute of Mental Health (NIMH). His work bridges molecular neuroscience with behavioral outcomes, focusing on how stress and substance exposure alter prefrontal cortical function. His research portfolio demonstrates consistent high-impact publication in top neuroscience journals including Nature Neuroscience , Neuron , and Psychoneuroendocrinology . Current work examines opioid neuropeptide dynamics, nicotine-alcohol interactions, and sex-specific hormonal influences on addiction behaviors. Methodologically, he specializes in genetically encoded biosensors and circuit-level manipulations to study threat processing and reward pathways. Dr. Flores teaches graduate and undergraduate courses including PSYC 4341 (Motivation & Emotion), thesis/dissertation supervision (PSYC 5395/6395), and research applications courses. His lab actively trains students through undergraduate research (RSRC 4033) and independent study opportunities (PSYC 4352).

Benjamin Drussمشاهده پروفایل

استاد

• Mental Health
• Health Policy
• Public Health
• +۳ مورد دیگر

Benjamin Druss is a Professor and Rosalynn Carter Chair in Mental Health at Emory University’s Rollins School of Public Health, Department of Health Policy and Management. He is a psychiatrist integrating mental health, physical health, and public health. His research focuses on improving care access/outcomes for populations with serious mental illnesses and medical comorbidities. He serves on JAMA Psychiatry’s editorial board and previously on NIMH’s National Advisory Council. Education: MD, New York University MPH, Yale University Research Interests: Health policy for mental health systems Social determinants of mental health Psychosis and comorbidity mechanisms Healthcare access disparities Articles Trends: Recent work examines opioid use patterns, mental health policy impacts, and neighborhood effects on psychiatric outcomes. Over 15 years of publications consistently address disparities in mental health care access and systemic solutions. Awards: APA Health Services Research Senior Scholar Award Carl Taube Award for Lifetime Contribution NAMI Exemplary Psychiatrist Award Advising/Grants: Leads research on mental health workforce resilience and Medicaid policy. Courses taught include mental health/medical policy, public mental health case studies, and dissertation guidance.

Jessica J. Walshمشاهده پروفایل

استادیار

• Neural Circuits
• Motivated Behavior
• Social Behavior
• +۴ مورد دیگر

Jessica J. Walsh, PhD is an Assistant Professor in the Department of Pharmacology at the University of North Carolina at Chapel Hill School of Medicine and a member of the UNC Neuroscience Center. She leads the Walsh Lab, which focuses on understanding neural circuit mechanisms underlying motivated social behavior using a multi-level approach to elucidate the molecular and circuit mechanisms that govern social interactions and their alterations in disease states. Dr. Walsh earned her B.A. in Neuroscience & Behavior from Columbia University, where she began her research journey volunteering in Dr. Gerald Fischbach's laboratory. During her graduate work, she explored neural circuit mechanisms underlying social stress susceptibility at the Icahn School of Medicine at Mount Sinai under Dr. Ming-Hu Han. Prior to joining UNC, she completed her postdoctoral fellowship at Stanford University with Dr. Robert Malenka, investigating neural circuit mechanisms in genetic mouse models with social deficits. Her research focuses on neural circuit mechanisms underlying motivated behavior, neurodevelopmental and psychiatric disorders, and functional/anatomical brain mapping. The Walsh Lab specifically uses genetic mouse models to investigate how genetic mutations and experience lead to circuit adaptations that govern impaired behavior seen in autism spectrum disorders. They combine whole brain optical clearing methods, light sheet microscopy, in vivo imaging, and machine learning based behavioral analysis to elucidate neural adaptations responsible for motivated behavior. Her publication record demonstrates a strong focus on neural circuits related to social behavior, with particular emphasis on autism spectrum disorders, serotonin and dopamine signaling, and the neural basis of prosocial behaviors. She has published extensively in high-impact journals including Nature, Nature Neuroscience, PNAS, and Neuropsychopharmacology, with research spanning from molecular mechanisms to circuit-level analyses of behavior. Dr. Walsh mentors several trainees in her lab, including a postdoctoral fellow, multiple graduate students, and numerous undergraduate researchers. Her lab team includes researchers with diverse interests spanning from molecular biology to machine learning applications in neuroscience. The lab actively recruits postdocs and graduate students interested in joining their research on motivated behavior and psychiatric disorders. The Walsh Lab employs a comprehensive research approach including genetic manipulation, whole brain activity mapping, viral tracing, slice physiology, optogenetics, chemogenetics, fiber photometry, and machine learning based behavioral classification to gain a nuanced understanding of neural circuits involved in motivated social behavior.

Danilo Bzdokمشاهده پروفایل

دانشیار

• Computational Biology
• Deep Learning
• Large Language Models (LLM)
• +۵ مورد دیگر

Danilo Bzdok is an Associate Professor in the Department of Biomedical Engineering at McGill University’s Faculty of Medicine and a Canada CIFAR AI Chair at Mila – Quebec Artificial Intelligence Institute. He holds dual expertise in systems neuroscience and machine learning, with two doctoral degrees: one in neuroscience from Forschungszentrum Jülich (Germany) and another in computer science (machine learning statistics) from INRIA–Saclay and Neurospin (France). His research bridges computational neuroscience and AI, focusing on understanding human intelligence through neuroimaging and biomedical data. Education: PhDs in Neuroscience (Jülich) and Computer Science (INRIA/Neurospin). Postdoctoral training at Harvard Medical School. Current affiliations include McGill University and Mila. Research interests span computational biology, deep learning, LLMs, and their applications in neuroimaging, precision medicine, and neurodegenerative diseases. Over 150+ peer-reviewed publications, with recent work on LLMs in autism diagnostics, brain network modeling, and social neuroscience. Key Awards: Canada CIFAR AI Chair. Lab focuses on interdisciplinary projects like AI4Science, neuroimaging analysis, and AI ethics. Supervises a dynamic team of PhD/Master’s students and postdocs. Collaborations include clinical institutions and industry partners through Mila’s Applied Research programs.

• Alcoholism
• Comorbidity
• Neurobiology
• +۵ مورد دیگر

Ismene Petrakis is a Professor of Psychiatry at Yale School of Medicine and Director of the Mental Health Service Line at VA Connecticut Healthcare System since 2010. She also leads the ACGME-accredited Addiction Psychiatry Residency program at Yale and serves as Principal Investigator for NIAAA- and NIDA-funded training grants . Her clinical and research focus bridges alcohol dependence , comorbid psychiatric disorders , and veterans' health . Research Pillars : Pharmacotherapies for dually diagnosed patients Neurobiological mechanisms of alcoholism PTSD-alcohol comorbidity Genetic risk in substance use Methodological Expertise : Multicenter clinical trials Neurotransmitter system analysis Population-based epidemiology Translational neuroscience Key Publications (2024-2025) : Investigations into GLP1R gene expression in kidney disease Dexmedetomidine for comorbid alcohol-PTSD Cognitive training combinations for alcohol use disorder PTSD treatment effects on neurobiological markers Chronic pain-alcohol use syndemic Collaborative Networks : Yale-Drug use, Addiction, and HIV prevention Research Scholars Neuroscience Research Training Program Collaboration with Department of Anesthesiology

• Addictive Disorders
• Genetics
• Substance Use Disorders
• +۳ مورد دیگر

Yaira Zoé Núñez is a Researcher in the Division of Human Genetics at the Yale School of Medicine. Her work focuses on genetic and epidemiological factors underlying substance use disorders, including cannabis, opioid, alcohol, and methamphetamine addictions. She collaborates extensively with the Gelernter Lab and other institutions on large-scale genomic studies. Research Interests: Genetic basis of addictive disorders Multi-ancestry genome-wide association studies (GWAS) Epidemiology of polysubstance use Clinical correlates of substance use disorders Key Collaborations: Works with Prof. Joel Gelernter, Renato Polimanti, and international teams. Recent studies include: Multicenter analysis of gambling disorder in methamphetamine users (2025) Multi-ancestry cannabis use disorder GWAS (2023) Genetic risk loci for opioid use disorder (2022) Labs/Teams: Core member of the Gelernter Lab, contributing to translational research bridging genetics and clinical addiction medicine. Active in collaborative networks analyzing large-scale biomedical data.

TANIA FERNÁNDEZ VILLAمشاهده پروفایل

دانشیار

• Preventive Medicine
• Public Health
• Nutritional Epidemiology
• +۵ مورد دیگر

Tania Fernández Villa is an Associate Professor in the Department of Biomedical Sciences at the Faculty of Veterinary Medicine, University of León. Her primary academic affiliation centers on preventive medicine and public health research within the GIIGAS (Interactions Gene-Environment-Health) research group. Her research spans nutritional epidemiology, gender studies in food systems, substance use disorders, and chronic disease prevention. Key focus areas include alcohol consumption patterns among university students (via the UniHcos cohort), sarcopenia in metabolic syndrome, breast cancer risk factors, and pandemic impacts on health behaviors. Her work integrates longitudinal cohort analysis, systematic reviews, and psychometric validation studies. Recent publications demonstrate strong trends in gender-disaggregated health research, pandemic-related behavioral shifts, and methodological innovations in dietary assessment. Her 2024-2025 output shows increasing emphasis on environmental sustainability of diets and multi-cancer risk prediction models. She serves on the editorial board of the Spanish Journal of Human Nutrition and Dietetics, contributing to strategic planning (2020-2026) and open science initiatives. Her PhD from Universidad de Granada focused on ICT usage patterns among university students. Current projects include the UniHcos longitudinal study tracking health behaviors in Spanish university students, with particular attention to alcohol use, sleep patterns, and nutritional status. Her research group actively investigates gene-environment interactions in public health contexts.

• Psychiatric Genetics
• Substance Use Disorders
• Gene-Environment Interaction
• +۵ مورد دیگر

Bao-Zhu Yang is a Researcher at Yale School of Medicine , specializing in the Department of Psychiatry . With a PhD from University at Albany (2001), his work focuses on genetic mechanisms underlying psychiatric disorders. Positions: Research Scientist in Psychiatry Labs: Gelernter Lab, Division of Human Genetics His research explores gene-environment interactions , admixture mapping , and comorbid substance use-depression using linkage/association methods. Supported by NIH K01 funding, he investigates genetic bases for conditions including childhood depression , alcoholism , and PTSD . Recent publications highlight: Microbiome studies in methamphetamine use disorder (2023-2025) Genetic polymorphism analyses in NGF and GABAergic pathways (2020-2024) Network approaches to nicotine-alcohol comorbidity (2019) Epigenetic research on child maltreatment effects (2020) Scientific Recognition: Young Investigator Award (2011) from NARSAD Brain and Behavior Research Foundation Active grant support includes NIH K01 career development award for gene-mapping in comorbid disorders. Collaborates with leading researchers including Joel Gelernter and Hongyu Zhao across 30+ joint publications. His work spans 15+ years with recent focus on integrative -omics approaches to addiction psychiatry. Based at 300 George St, New Haven, CT , Yang's laboratory work involves genetic epidemiology , transcriptomic integration , and neurogenetic mapping of substance use disorders.

• Medical Biometry
• Epidemiology
• Cognitive Dysfunction
• +۴ مورد دیگر

Insa Feinkohl is a Professor at the Chair of Medical Biometry and Epidemiology within the Faculty of Health at the University of Witten/Herdecke . Her research focuses on risk factors for cognitive dysfunction and mental health in older adults, particularly post-surgery, with emphasis on metabolic and cognitive risk factors. Bachelor of Science (BSc) in Psychology (1 st class honors) – University of Dundee (2006-2009) Master of Science (MSc) in Psychology of Individual Differences (with distinction) – University of Edinburgh (2009-2010) PhD in Community Health Sciences – University of Edinburgh (2010-2014) Post Doc in Knowledge Construction Group – Leibniz Institute for Knowledge Media, Tübingen (2014-2015) Postdoc in Molecular Epidemiology Group – Max Delbrück Center, Berlin (2015-2022) Habilitation in Molecular Epidemiology – Charité Universitätsmedizin Berlin (2021) Her research integrates medical biometry and epidemiology to study postoperative cognitive dysfunction (POCD), delirium, and aging-related cognitive decline. Key areas include biomarker validation (e.g., leptin, interleukins), brain connectivity (dopaminergic networks, thalamus), and metabolic risk factors (diabetes, obesity). She contributed to the BioCog project , an EU-funded initiative for personalized risk prediction of postoperative cognitive impairment. Her recent publications highlight trends in perioperative neuroscience, including brain mineralization, cytokine associations with neurocognitive disorders, and structural/functional imaging in delirium. Articles also explore metabolic syndrome, cognitive reserve, and delirium prediction models using machine learning. Insa Feinkohl is affiliated with major academic societies, including the German Society for Epidemiology , German Society for Medical Informatics, Biometry and Epidemiology , and the German University Association .

Stuart Robertsمشاهده پروفایل

عضو هیئت علمی

• Hepatology
• Chronic Viral Hepatitis
• Primary Liver Cancer
• +۹ مورد دیگر

Stuart Roberts is an Adjunct Clinical Professor in the Department of Gastroenterology at Monash University, Faculty of Medicine, Nursing and Health Sciences. He is actively engaged in clinical research focusing on liver diseases, with a strong emphasis on chronic viral hepatitis, primary liver cancer, non-alcoholic fatty liver disease (NAFLD/MASLD), and non-invasive liver diagnostics such as Fibroscan. University: Monash University School: Faculty of Medicine, Nursing and Health Sciences Department: Department of Gastroenterology Academic Rank: Adjunct Clinical Professor His research interests center on advancing therapeutic strategies for chronic liver diseases through clinical trials and translational studies. Key areas include evaluating novel antiviral and immunomodulatory agents for hepatitis B and C, assessing new treatments for hepatocellular carcinoma, and investigating metabolic and dietary influences on liver health in aging populations. He also studies the role of liver stiffness measurement in disease screening and prognosis. The recent publications and active research projects (2024–2025) reflect a strong trend toward understanding the intersection of liver disease with aging, cardiovascular health, and neurocognitive outcomes. His work increasingly focuses on metabolic dysfunction-associated steatotic liver disease (MASLD), its systemic complications, and lifestyle or pharmacological interventions. Multiple phase 1 to phase 3 clinical trials are underway, particularly in NASH/MASH, hepatitis B immunotherapy, and cholangiocarcinoma. Scientific Awards: No awards mentioned in the provided text. Advising and Grants: Dr. Roberts serves as Primary Chief Investigator on 42 research projects, including major industry-sponsored clinical trials in hepatology. His leadership in multicenter studies highlights his role in shaping evidence-based liver disease management. While no formal student advising is mentioned, his collaborations involve trainees and junior researchers. Funding appears to come from pharmaceutical sponsors and institutional sources, supporting trials in antiviral, metabolic, and oncologic liver therapies. Labs and Research Teams: Dr. Roberts leads a clinical research team focused on hepatology within Monash Health. His work is highly collaborative, involving dietitians, oncologists, geriatricians, and neurologists. The research network includes national and international partners, with a strong presence in Australian multicenter liver disease studies.

• Internal Medicine
• Breast Cancer Research
• Clinical Informatics
• +۳ مورد دیگر

Deborah Rhodes is a Professor in General Internal Medicine at the Yale School of Medicine , with a focus on clinical informatics, breast cancer research, and health equity. She serves as the Enterprise Chief Quality Officer for Yale Medicine, Northeast Medical Group, and Yale New Haven Health System. MD (1992) from Weill Cornell Medical College BA (1986) in History and Literature from Harvard College Her research integrates clinical pathways for alcohol use disorder management and breast cancer screening accessibility, particularly for underserved populations. Recent work includes randomized trials on breast density notification impacts and electronic care pathway implementation. Key collaborations include studies with Benjamin Judson , David Fiellin , and Luming Li , focusing on interdisciplinary applications of clinical informatics and quality improvement initiatives.